LAS VEGAS, April 27, 2018 -- VITALIBIS, INC. (OTCQB:VCBD) a technology-based seller of premium, full spectrum phyto-cannabinoid rich (PCR) hemp oil products, along with personal care and certified organic nutritional products formulated with premium hemp extracts, announced today that its stock has commenced trading on the OTCQB Market (“OTCQB”) after successfully uplisting from the OTC Pink Market.
While OTCQB membership requires more comprehensive compliance requirements from its members, it correspondingly provides significantly enhanced investor benefits, including higher reporting standards, increased analyst coverage and access to news services.
Steven Raack, CEO of Vitalibis said, "As we build the Vitalibis brand, our goal is to consistently improve – with our product formulations, with our technology innovation and with our social impact. Upticking to OTCQB is another positive improvement. Trading on the OTCQB will provide our shareholders and prospective investors a greater degree of transparency and liquidity."
About Vitalibis, Inc.
Vitalibis endeavours to be an iconic lifestyle brand, which promotes health and wellness within the rapidly growing medicinal cannabis industry. Vitalibis seeks to utilize a robust technology platform and innovative micro-influencer sales model to market and sell premium, full spectrum phyto-cannabinoid rich (PCR) hemp oil products, along with personal care and certified organic nutritional products formulated with premium hemp extracts. In addition to leveraging technology and selling high-quality products, Vitalibis will focus on supporting non-profits with environmental and neuro-emotional missions.
For additional information, www.vitalibis.com
Contact:
Vitalibis Inc.
702-944-9620
[email protected]
FORWARD LOOKING STATEMENT
This news release includes forward-looking statements that reflect Vitalibis Inc. current expectations about its future results, performance, prospects and opportunities Vitalibis, Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities for the remainder of 2018 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.


Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
World game at war: why some European nations have threatened a World Cup boycott
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 



